Dr. Gregg Stone and Dr. C. Michael Gibson Discuss: Impact Of Completeness Of Revascularization On Clinical Outcomes In Patients With Stable Ischemic Heart Disease Treated With An Invasive Vs. Conservative Strategy: The ISCHEMIA Trial May 15, 2021 Disclosures: TBD
Dr. Behnood Bikdeli and Dr. C. Michael Gibson Discuss: Atorvastatin Versus Placebo In Critically-ill Patients With Covid-19: The Inspiration-S Double Blind Randomized Controlled Trial May 15, 2021 Disclosures: TBD
Dr. John Teerlink and Dr. C. Michael Gibson Discuss: Impact Of Ejection Fraction On The Therapeutic Effect Of Omecamtiv Mecarbil In Patients With Heart Failure And Reduced Ejection Fraction: A Secondary Analysis From GALACTIC-HF May 15, 2021 Disclosures: TBD
Dr. Douglas Mann and Dr. C. Michael Gibson Discuss: Sacubitril/Valsartan (LCZ696) In Patients With Advanced Heart Failure And Reduced Ejection Fraction: Results Of The LIFE Trial May 15, 2021 Disclosures: TBD
Dr. Rupert Bauersachs and Dr. C. Michael Gibson Discuss: Reductions In Total Ischemic Events With Rivaroxaban In Patients With Symptomatic Pad After Revascularization: The VOYAGER PAD Trial May 15, 2021 Disclosures: TBD
Dr. Robert Byrne and Dr. C. Michael Gibson Discuss: COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Coated Stent With 14 Days DAPT in High-Bleeding Risk Patients October 17, 2020 Disclosures: TBD
Dr. Damien Collison and Dr. C. Michael Gibson Discuss: TARGET FFR: A Randomized Trial of Physiology-Guided PCI Optimization October 16, 2020 Disclosures: TBD
Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss: Disrupt CAD III: Safety and Effectiveness of Intravascular Lithotripsy for Treatment of Severe Coronary Calcification October 16, 2020 Disclosures: TBD
Dr. Junjie Zhang and Dr. C. Michael Gibson Discuss: ULTIMATE: Three-Year Outcomes After IVUS-Guided vs Angiography Guided DES Implantation October 15, 2020 Disclosures: TBD
Dr. Jeffrey Moses and Dr. C. Michael Gibson Discuss: REFLECT II: A Randomized Trial of a Cerebral Embolic Protection Device During TAVR October 15, 2020 Disclosures: TBD
